Therefore, there is a very low risk of B12 toxicity, even at high doses like 1,000 mcg a day
Now, online businesses are trying to cash in on the craze by selling skin patches marketed for weight loss that include GLP-1 in the product name, but are not actually GLP-1 agonist drugs
Retatrutide is an investigational injectable triple agonist developed by Eli Lilly that simultaneously activates GIP, GLP-1, and glucagon receptors to produce complementary metabolic effects, including appetite suppression and potential increases in energy expenditure
These classes are organized according to the protein sequence and structure
If diarrhea occurs, ensure adequate hydration and electrolyte replacement
They depend on each other